2268 related articles for article (PubMed ID: 12808062)
21. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
[TBL] [Abstract][Full Text] [Related]
22. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
[TBL] [Abstract][Full Text] [Related]
24. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.
Araujo I; Foss HD; Hummel M; Anagnostopoulos I; Barbosa HS; Bittencourt A; Stein H
J Pathol; 1999 Feb; 187(3):326-30. PubMed ID: 10398087
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells.
Weinreb M; Day PJ; Murray PG; Raafat F; Crocker J; Parkes SE; Coad NA; Jones JT; Mann JR
J Pathol; 1992 Dec; 168(4):365-9. PubMed ID: 1336543
[TBL] [Abstract][Full Text] [Related]
26. [Molecular characterization of Epstein-Barr virus associated with classical Hodgkin's lymphoma in Tunisia: prevalence of the LMP1 oncogene deletions and A and B viruses strains].
Trimeche M; Korbi S; Ziadi S; Amara K; Boniver J; de Leval L
Ann Biol Clin (Paris); 2005; 63(2):193-9. PubMed ID: 15771977
[TBL] [Abstract][Full Text] [Related]
27. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
28. [Epstein-Barr virus presence in Colombian Hodgkin lymphoma cases and its relation to treatment response].
Quijano S; Saavedra C; Fiorentino S; Orozco O; Bravo MM
Biomedica; 2004 Jun; 24(2):163-73. PubMed ID: 15495596
[TBL] [Abstract][Full Text] [Related]
29. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
Koh YW; Yoon DH; Suh C; Huh J
Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease.
Alkan S; Ross CW; Hanson CA; Schnitzer B
Mod Pathol; 1995 Jun; 8(5):544-7. PubMed ID: 7675775
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus in Hodgkin's disease patients in Japan.
Tomita Y; Ohsawa M; Kanno H; Hashimoto M; Ohnishi A; Nakanishi H; Aozasa K
Cancer; 1996 Jan; 77(1):186-92. PubMed ID: 8630928
[TBL] [Abstract][Full Text] [Related]
32. Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood.
Kanavaros P; Sakalidou A; Gaulard P; Jiwa M; Delides G; Tzardi M; Kalmantis T; Lydaki E; Kazlaris E; Kalmanti M
Acta Morphol Hung; 1992; 40(1-4):223-30. PubMed ID: 1365766
[TBL] [Abstract][Full Text] [Related]
33. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico.
Quintanilla-Martínez L; Gamboa-Domńquez A; Gamez-Ledesma I; Angeles-Angeles A; Mohar A
Mod Pathol; 1995 Aug; 8(6):675-9. PubMed ID: 8532705
[TBL] [Abstract][Full Text] [Related]
34. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
Delsol G; Brousset P; Chittal S; Rigal-Huguet F
Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
[TBL] [Abstract][Full Text] [Related]
35. Association between the Epstein-Barr virus and Hodgkin's lymphoma in the North-Eastern part of Hungary: effects on therapy and survival.
Keresztes K; Miltenyi Z; Bessenyei B; Beck Z; Szollosi Z; Nemes Z; Olah E; Illes A
Acta Haematol; 2006; 116(2):101-7. PubMed ID: 16914904
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.
Sleckman BG; Mauch PM; Ambinder RF; Mann R; Pinkus GS; Kadin ME; Sherburne B; Perez-Atayde A; Thior I; Mueller N
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1117-21. PubMed ID: 9865430
[TBL] [Abstract][Full Text] [Related]
37. Association of Hodgkin's lymphoma with Epstein Barr virus infection.
Cickusić E; Mustedanagić-Mujanović J; Iljazović E; Karasalihović Z; Skaljić I
Bosn J Basic Med Sci; 2007 Feb; 7(1):58-65. PubMed ID: 17489771
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
[TBL] [Abstract][Full Text] [Related]
39. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
40. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
Liu JR; Lin Q; Wu XY
Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]